-
Benzinga's Top Pre-Market NASDAQ Losers (BMTI, MNKD, HEAT, ATPG)
Tuesday, May 10, 2011 - 8:26am | 135BioMimetic Therapeutics Inc (NASDAQ: BMTI) dipped 18.67% to $10.89 in the pre-market session. BMTI reported a Q1 net loss of $8.0 million. MannKind Corporation (NASDAQ: MNKD) fell 14.09% to $3.78 in the pre-market session. MNKD reported wider-than-expected Q1 loss. Food and Drug Administration (...
-
Analysts Stock Upgrade And Downgrade For Mayl 10, 2011- SVNT, SVA, TLAB, INFI, LUV, GSIC, ARG, MTSC, ANF, TE, ASEI, SMT, DRWI, OXY, SPRD, CCIH
Tuesday, May 10, 2011 - 8:22am | 1160Lazard Capital downgraded shares of Savient Pharmaceuticals Inc. (SVNT) from a “buy” rating to a “neutral” rating, JPMorgan Chase & Co. (JPM) downgraded shares of Savient Pharmaceuticals Inc. from an “overweight” rating to a “neutral” rating as well. Zacks Investment Research upgraded shares...
-
UPDATE: Wedbush Raises PT on Oncothyreon to $7 (ONTY)
Tuesday, May 10, 2011 - 8:20am | 83Wedbush is out with its report today on Oncothyreon (NASDAQ: ONTY), raising its PT from $6 to $7. In a note to clients, Wedbush writes, "Our new price target of $7 is derived from applying a 6X multiple to estimated 2015 revenues, discounted by 50% annually given the history of therapeutic cancer...
-
Hapoalim Reiterating Sell On MannKind (MNKD)
Tuesday, May 10, 2011 - 8:17am | 147Hapoalim Securities is reiterating its Sell rating and $1 price target on shares of MannKind (NASDAQ: MNKD). In a note to investors, Hapoalim writes, "MannKind announced that it has met with the FDA for an End-of-Review meeting for the Afrezza program and while the FDA seems to have agreed on the...
-
Myriad Genetics Licenses Novel Technology From Chronix Biomedical (MYGN)
Tuesday, May 10, 2011 - 8:17am | 163Myriad Genetics, Inc. (Nasdaq: MYGN) today announced that it has signed an agreement to license proprietary technology for the early detection of cancer from Chronix Biomedical of San Jose, California. Under the agreement, Myriad has rights in North America, South America, and Europe to...
-
J.P. Morgan Maintains Underweight on MannKind (MNKD)
Tuesday, May 10, 2011 - 8:02am | 84J.P. Morgan is out with its report today on MannKind (NASDAQ: MNKD), maintaining Underweight. In a note to clients, J.P. Morgan writes, "We maintain our UW on MNKD following the 1Q update post close. We remain surprised the company has maintained an ~$950M EV in the face of an increasingly tenuous...
-
Gentium Announces Submission of a Marketing Authorization Application for Defibrotide to the European Medicines Agency (GENT)
Tuesday, May 10, 2011 - 7:44am | 135Gentium S.p.A. (Nasdaq: GENT) today announced it has submitted a Marketing Authorization Application, under the centralized licensing procedure, to the European Medicines Agency for Defibrotide for the treatment and prevention of hepatic veno-occlusive disease in haematopoietic stem-cell...
-
Oncolytics Biotech Inc. Announces Phase I Multiple Myeloma Cancer Study
Tuesday, May 10, 2011 - 7:39am | 106Oncolytics Biotech Inc. (NASDAQ: ONCY) announced today that the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute, which is part of the National Institutes of Health, has agreed to sponsor a Phase I study of REOLYSIN alone in patients with...
-
US Stock Futures Up After China Trade Surplus; All Eyes On Microsoft
Tuesday, May 10, 2011 - 6:38am | 567US stock futures are higher this morning, as China reported stronger-than-expected trade surplus. Microsoft Corp (NASDAQ: MSFT) is reportedly nearing a deal to purchase Internet phone company Skype Technologies. Futures on the Dow Jones Industrial Average gained 39 points to 12,670.00 and futures...
-
Earnings Scheduled For May 10 (DF, MCP, DIS, ACMR, MBI, MDR, WEN, ACAD, BLD, LIWA, AHCI, FRM, BKH, TAST, RDNT)
Tuesday, May 10, 2011 - 2:13am | 405Dean Foods Co (NYSE: DF) is projected to report its Q1 EPS at $0.06 on revenue of $3.07 billion. Molycorp Inc (NYSE: MCP) is estimated to post its Q1 EPS at $0.10 on revenue of $41.68 million. Walt Disney Company (NYSE: DIS) is projected to report its FQ2 EPS at $0.56 on revenue of $9.13...
-
Stocks To Watch For May 10 (DIS, MNKD, MDR, MSFT, WEN)
Tuesday, May 10, 2011 - 1:36am | 251Some of the stocks that may grab investor focus today are: Wall Street expects Walt Disney Company (NYSE: DIS) to report its FQ2 EPS at $0.56 on revenue of $9.13 billion. DIS shares gained 0.23% to $43.20 in after-hours trading. MannKind Corp (NASDAQ: MNKD) reported a Q1 loss at $41.5 million, or...
-
Buyers Flexing Muscles 05-09-2011
Monday, May 9, 2011 - 6:34pm | 931Cusick's Corner Buyers are flexing their muscles into the Midday after what seemed to be a potentially shaky open with the Dollar firming and the S&P downgrade of Greece. While the commodity sector will need some more economic confidence building before Funds and Specs come back into those...
-
Trade Ideas for Tuesday, May 10
Monday, May 9, 2011 - 5:37pm | 2082( click to enlarge ) There is an interesting pattern developing in FormFactor, Inc. (NASDAQ:FORM). The stock has been consolidating for several months after a horrific decline last year. The Volume has been gradually building on the right side of the base, and stock is testing again its 50-day...
-
MannKind Drops After Hours After FDA Will Not Likely Accept Ongoing Trials (MNKD)
Monday, May 9, 2011 - 4:36pm | 140MannKind (NASDAQ: MNKD) falls today in after-hours trading as FDA tells the company it will not likely accept ongoing trials of MannKind's AFREZZA. “We recently held a productive End-of-Review meeting with the FDA regarding the path forward for AFREZZA,” said Alfred Mann, Chairman and Chief...
-
PDL BioPharma Announces Proposed $135 Million Public Offering of New Convertible Senior Notes Due 2015 (PDLI)
Monday, May 9, 2011 - 4:10pm | 188PDL BioPharma (NASDAQ: PDLI) today announced that it intends to offer, subject to market and other conditions, $135 million aggregate principal amount of new convertible senior notes due May 2015 under the Company's shelf registration statement filed with the U.S. Securities and Exchange Commission...